Review



antibodies goat anti sparcl1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems antibodies goat anti sparcl1
    A Pedigree structure and segregation of a <t>SPARCL1</t> variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Antibodies Goat Anti Sparcl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies goat anti sparcl1/product/R&D Systems
    Average 94 stars, based on 33 article reviews
    antibodies goat anti sparcl1 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant"

    Article Title: Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant

    Journal: European Journal of Human Genetics

    doi: 10.1038/s41431-024-01687-8

    A Pedigree structure and segregation of a SPARCL1 variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Figure Legend Snippet: A Pedigree structure and segregation of a SPARCL1 variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].

    Techniques Used: Variant Assay, Amplification, Sequencing, Functional Assay, Protease Inhibitor, Binding Assay, Derivative Assay, RNA Sequencing Assay, Expressing

    A , E Merge of DAPI and SPARCL1 channels show an upregulation of SPARCL1 in the epithelial layer of the affected tissue. B , F Merge DAPI and decorin channels. The downregulation of decorin is evident in the stroma of the affected tissue. C , G Merge of all three channels. Scale bars correspond to 50 μm. D , H Magnification box of ( C ) and ( G ), respectively, scale bars correspond to 5 μm, perinuclear co-localisation of SPARCL1 and decorin is observed in affected tissue.
    Figure Legend Snippet: A , E Merge of DAPI and SPARCL1 channels show an upregulation of SPARCL1 in the epithelial layer of the affected tissue. B , F Merge DAPI and decorin channels. The downregulation of decorin is evident in the stroma of the affected tissue. C , G Merge of all three channels. Scale bars correspond to 50 μm. D , H Magnification box of ( C ) and ( G ), respectively, scale bars correspond to 5 μm, perinuclear co-localisation of SPARCL1 and decorin is observed in affected tissue.

    Techniques Used:



    Similar Products

    94
    R&D Systems antibodies goat anti sparcl1
    A Pedigree structure and segregation of a <t>SPARCL1</t> variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Antibodies Goat Anti Sparcl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies goat anti sparcl1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    antibodies goat anti sparcl1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    R&D Systems goat anti hevin
    A Pedigree structure and segregation of a <t>SPARCL1</t> variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Goat Anti Hevin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti hevin/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    goat anti hevin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    94
    R&D Systems sparcl1 goat igg r d systems af2728
    A Pedigree structure and segregation of a <t>SPARCL1</t> variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Sparcl1 Goat Igg R D Systems Af2728, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sparcl1 goat igg r d systems af2728/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    sparcl1 goat igg r d systems af2728 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti sparcl1
    A Pedigree structure and segregation of a <t>SPARCL1</t> variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].
    Goat Anti Sparcl1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti sparcl1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    goat anti sparcl1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    R&D Systems immunoblotting goat anti hevin
    Hevin mutants lacking the EF-hand motif activate the UPR signaling caused by abnormal trafficking. ( A ) <t>Immunoblotting</t> of Hevin WT and mutants (ΔEF and N11). Neuro-2a cells were transfected for 48 h with expression vectors for Hevin WT or mutants (ΔEF or N11). The cell lysates and conditioned medium were subjected to immunoblot analysis using anti-Hevin and Tubulin antibodies. ( B ) Immunostaining of Hevin and mutants (ΔEF and N11). HeLa cells were transfected for 24 h with expression vectors for Hevin and mCherry-ER and subjected to immunocytochemistry. Scale bar: 10 μm. ( C ) Quantification of Pearson’s correlation coefficient as the degree of colocalization in the panel B. n = 20 cells, mean ± standard error of the mean (SEM), ** p < 0.01, *** p < 0.001 versus Hevin WT, one-way analysis of variance (ANOVA) Dunnett’s test. ( D , E ) Total RNAs isolated from the Hevin-overexpressed Neuro-2a cells were conducted with qPCR analysis for measurement of Bip and Chop mRNAs. 5S rRNAs were used for normalization. n = 5; mean ± SEM; * p < 0.05, ** p < 0.01 versus Hevin WT, one-way ANOVA Dunnett’s test calculated using the ΔCt value. ( F ) Immunoblotting of BIP, Hevin, and Tubulin. HEK293T cells were transfected for 72 h with expression vectors for Hevin WT or mutants (ΔEF or N11). Cells were stimulated with 500 nM Thapsigarging (Tg) for 24 h. The cells were then subjected to immunoblot analysis using anti-BIP, Hevin and Tubulin antibodies.
    Immunoblotting Goat Anti Hevin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunoblotting goat anti hevin/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    immunoblotting goat anti hevin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    A Pedigree structure and segregation of a SPARCL1 variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].

    Journal: European Journal of Human Genetics

    Article Title: Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant

    doi: 10.1038/s41431-024-01687-8

    Figure Lengend Snippet: A Pedigree structure and segregation of a SPARCL1 variant. *DNA available. WGS whole genome sequenced. SPARCL1 , NM_004684: c.334G > A; p.(Glu112Lys), +/− heterozygous variant identified, +/+ wild type on both alleles, verified by PCR amplification and Sanger sequencing. B Sanger sequencing chromatogram of SPARCL1 exon 4 in affected individual III:8 demonstrating a heterozygous c.334G > A. C The functional motifs are as follows: signal peptide; FOLN (follistatin/osteonectin-like EGF domain); Kazal 1 (Kazal-type serine protease inhibitor domain); SPARC Ca bdg (secreted protein acidic and rich in cysteine Ca binding region). The disordered regions, parts of the protein lacking definition, are represented by light grey shading. Low-complexity regions are represented in blue shading. p.(Glu112Lys) is located in a disordered region of the protein. Domains are derived from data in Pfam. D Conservation of protein sequence across 14 species. E RNA-seq transcript expression of SPARCL1 in the different layers of the cornea. BLC basal limbal crypts, SLC superficial limbal crypts. Data were curated from bulk RNA-seq and presented as transcripts per million (TPM) [ , ].

    Article Snippet: Sections were incubated in primary antibodies goat anti-SPARCL1 (AF2728, R&D Systems, Minneapolis, MN, USA, 1:50) and rabbit anti-DCN (LF-122, Kerafast, Boston, MA, USA, 1:200), at room temperature for 1.5 h then 4 °C overnight.

    Techniques: Variant Assay, Amplification, Sequencing, Functional Assay, Protease Inhibitor, Binding Assay, Derivative Assay, RNA Sequencing Assay, Expressing

    A , E Merge of DAPI and SPARCL1 channels show an upregulation of SPARCL1 in the epithelial layer of the affected tissue. B , F Merge DAPI and decorin channels. The downregulation of decorin is evident in the stroma of the affected tissue. C , G Merge of all three channels. Scale bars correspond to 50 μm. D , H Magnification box of ( C ) and ( G ), respectively, scale bars correspond to 5 μm, perinuclear co-localisation of SPARCL1 and decorin is observed in affected tissue.

    Journal: European Journal of Human Genetics

    Article Title: Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant

    doi: 10.1038/s41431-024-01687-8

    Figure Lengend Snippet: A , E Merge of DAPI and SPARCL1 channels show an upregulation of SPARCL1 in the epithelial layer of the affected tissue. B , F Merge DAPI and decorin channels. The downregulation of decorin is evident in the stroma of the affected tissue. C , G Merge of all three channels. Scale bars correspond to 50 μm. D , H Magnification box of ( C ) and ( G ), respectively, scale bars correspond to 5 μm, perinuclear co-localisation of SPARCL1 and decorin is observed in affected tissue.

    Article Snippet: Sections were incubated in primary antibodies goat anti-SPARCL1 (AF2728, R&D Systems, Minneapolis, MN, USA, 1:50) and rabbit anti-DCN (LF-122, Kerafast, Boston, MA, USA, 1:200), at room temperature for 1.5 h then 4 °C overnight.

    Techniques:

    Hevin mutants lacking the EF-hand motif activate the UPR signaling caused by abnormal trafficking. ( A ) Immunoblotting of Hevin WT and mutants (ΔEF and N11). Neuro-2a cells were transfected for 48 h with expression vectors for Hevin WT or mutants (ΔEF or N11). The cell lysates and conditioned medium were subjected to immunoblot analysis using anti-Hevin and Tubulin antibodies. ( B ) Immunostaining of Hevin and mutants (ΔEF and N11). HeLa cells were transfected for 24 h with expression vectors for Hevin and mCherry-ER and subjected to immunocytochemistry. Scale bar: 10 μm. ( C ) Quantification of Pearson’s correlation coefficient as the degree of colocalization in the panel B. n = 20 cells, mean ± standard error of the mean (SEM), ** p < 0.01, *** p < 0.001 versus Hevin WT, one-way analysis of variance (ANOVA) Dunnett’s test. ( D , E ) Total RNAs isolated from the Hevin-overexpressed Neuro-2a cells were conducted with qPCR analysis for measurement of Bip and Chop mRNAs. 5S rRNAs were used for normalization. n = 5; mean ± SEM; * p < 0.05, ** p < 0.01 versus Hevin WT, one-way ANOVA Dunnett’s test calculated using the ΔCt value. ( F ) Immunoblotting of BIP, Hevin, and Tubulin. HEK293T cells were transfected for 72 h with expression vectors for Hevin WT or mutants (ΔEF or N11). Cells were stimulated with 500 nM Thapsigarging (Tg) for 24 h. The cells were then subjected to immunoblot analysis using anti-BIP, Hevin and Tubulin antibodies.

    Journal: Scientific Reports

    Article Title: Autism-associated mutation in Hevin/Sparcl1 induces endoplasmic reticulum stress through structural instability

    doi: 10.1038/s41598-022-15784-5

    Figure Lengend Snippet: Hevin mutants lacking the EF-hand motif activate the UPR signaling caused by abnormal trafficking. ( A ) Immunoblotting of Hevin WT and mutants (ΔEF and N11). Neuro-2a cells were transfected for 48 h with expression vectors for Hevin WT or mutants (ΔEF or N11). The cell lysates and conditioned medium were subjected to immunoblot analysis using anti-Hevin and Tubulin antibodies. ( B ) Immunostaining of Hevin and mutants (ΔEF and N11). HeLa cells were transfected for 24 h with expression vectors for Hevin and mCherry-ER and subjected to immunocytochemistry. Scale bar: 10 μm. ( C ) Quantification of Pearson’s correlation coefficient as the degree of colocalization in the panel B. n = 20 cells, mean ± standard error of the mean (SEM), ** p < 0.01, *** p < 0.001 versus Hevin WT, one-way analysis of variance (ANOVA) Dunnett’s test. ( D , E ) Total RNAs isolated from the Hevin-overexpressed Neuro-2a cells were conducted with qPCR analysis for measurement of Bip and Chop mRNAs. 5S rRNAs were used for normalization. n = 5; mean ± SEM; * p < 0.05, ** p < 0.01 versus Hevin WT, one-way ANOVA Dunnett’s test calculated using the ΔCt value. ( F ) Immunoblotting of BIP, Hevin, and Tubulin. HEK293T cells were transfected for 72 h with expression vectors for Hevin WT or mutants (ΔEF or N11). Cells were stimulated with 500 nM Thapsigarging (Tg) for 24 h. The cells were then subjected to immunoblot analysis using anti-BIP, Hevin and Tubulin antibodies.

    Article Snippet: For immunoblotting goat anti-Hevin (1:1000, R&D Systems, Cat# AF2836), mouse anti-Tubulin (1:1000, Sigma, DM1A), rabbit anti-BIP (1:1000, Cell Signaling, CB0B12), and mouse anti-GST (1:500, Santa Cruz, B14) antibodies were used as primary antibodies.

    Techniques: Western Blot, Transfection, Expressing, Immunostaining, Immunocytochemistry, Isolation

    ASD-associated W647R mutant of Hevin activates the UPR signaling. ( A ) Location of ASD-associated Hevin mutations. ( B ) Amino acid of the EF-hand motif in each species. The human Trp 647 is highly conserved. Cyan indicates the EF-hand motif, Magenta indicates non-conserved amino acid. ( C ) Immunoblotting of Hevin WT and mW633R mutant. Neuro-2a cells were transfected with expression vectors and collected at the indicated times. The upper panel indicates the experimental schedule. The transfection efficiencies were confirmed by observing co-expressed EGFP fluorescence. The cell lysates and conditioned medium were subjected to immunoblot analysis using anti-Hevin and Tubulin antibodies. The secretion rate of the Hevin WR mutant was delayed more than that of WT. CM; conditioned medium, TCL: total cell lysate ( D ) Immunostaining of Hevin WT and mW633R mutant. HeLa cells were transfected for 24 h with expression vectors for Hevin and mCherry-ER and subjected to immunocytochemistry. Scale bar: 10 μm. ( E ) Quantification of Pearson’s correlation coefficient as the degree of colocalization in the panel D. n = 15 cells, mean ± SEM, *** p < 0.001 by Student’s t- test. ( F ) Immunostaining of Hevin and mW633R mutant. HeLa cells were transfected for 24 h with expression vectors for Hevin and subjected to immunocytochemistry. Scale bar: 10 μm. ( G ) Quantification of Manders’ coefficient as the degree of colocalization of Hevin with GM130 in the panel F. n = 20 cells, mean ± SEM, *** p < 0.001 by Student’s t- test. ( H , I ) Total RNAs isolated from the Hevin-overexpressed Neuro-2a cells were conducted with qPCR analysis for measurement of Bip and Chop mRNAs. 5S rRNA were used for normalization. n = 5; ** p < 0.01, *** p < 0.001 versus Hevin WT, one-way ANOVA Dunnett’s test calculated p -value using the ΔCt value. ( J ) Immunoblotting of BIP, Hevin, and Tubulin. Neuro-2a cells were transfected for 72 h with expression vectors for Hevin WT or mW633R mutants. The cell lysates were then subjected to immunoblot analysis using anti-BIP, Hevin, and Tubulin antibodies. ( K ) Schematic structure of GST-Hevin. ( L ) Pull down of GST-Hevin and endogenous BIP in HEK293T cells. GST-Hevin was precipitated with Glutathione Sepharose beads and immunoblotted with anti-GST, BIP, and Tubulin antibodies.

    Journal: Scientific Reports

    Article Title: Autism-associated mutation in Hevin/Sparcl1 induces endoplasmic reticulum stress through structural instability

    doi: 10.1038/s41598-022-15784-5

    Figure Lengend Snippet: ASD-associated W647R mutant of Hevin activates the UPR signaling. ( A ) Location of ASD-associated Hevin mutations. ( B ) Amino acid of the EF-hand motif in each species. The human Trp 647 is highly conserved. Cyan indicates the EF-hand motif, Magenta indicates non-conserved amino acid. ( C ) Immunoblotting of Hevin WT and mW633R mutant. Neuro-2a cells were transfected with expression vectors and collected at the indicated times. The upper panel indicates the experimental schedule. The transfection efficiencies were confirmed by observing co-expressed EGFP fluorescence. The cell lysates and conditioned medium were subjected to immunoblot analysis using anti-Hevin and Tubulin antibodies. The secretion rate of the Hevin WR mutant was delayed more than that of WT. CM; conditioned medium, TCL: total cell lysate ( D ) Immunostaining of Hevin WT and mW633R mutant. HeLa cells were transfected for 24 h with expression vectors for Hevin and mCherry-ER and subjected to immunocytochemistry. Scale bar: 10 μm. ( E ) Quantification of Pearson’s correlation coefficient as the degree of colocalization in the panel D. n = 15 cells, mean ± SEM, *** p < 0.001 by Student’s t- test. ( F ) Immunostaining of Hevin and mW633R mutant. HeLa cells were transfected for 24 h with expression vectors for Hevin and subjected to immunocytochemistry. Scale bar: 10 μm. ( G ) Quantification of Manders’ coefficient as the degree of colocalization of Hevin with GM130 in the panel F. n = 20 cells, mean ± SEM, *** p < 0.001 by Student’s t- test. ( H , I ) Total RNAs isolated from the Hevin-overexpressed Neuro-2a cells were conducted with qPCR analysis for measurement of Bip and Chop mRNAs. 5S rRNA were used for normalization. n = 5; ** p < 0.01, *** p < 0.001 versus Hevin WT, one-way ANOVA Dunnett’s test calculated p -value using the ΔCt value. ( J ) Immunoblotting of BIP, Hevin, and Tubulin. Neuro-2a cells were transfected for 72 h with expression vectors for Hevin WT or mW633R mutants. The cell lysates were then subjected to immunoblot analysis using anti-BIP, Hevin, and Tubulin antibodies. ( K ) Schematic structure of GST-Hevin. ( L ) Pull down of GST-Hevin and endogenous BIP in HEK293T cells. GST-Hevin was precipitated with Glutathione Sepharose beads and immunoblotted with anti-GST, BIP, and Tubulin antibodies.

    Article Snippet: For immunoblotting goat anti-Hevin (1:1000, R&D Systems, Cat# AF2836), mouse anti-Tubulin (1:1000, Sigma, DM1A), rabbit anti-BIP (1:1000, Cell Signaling, CB0B12), and mouse anti-GST (1:500, Santa Cruz, B14) antibodies were used as primary antibodies.

    Techniques: Mutagenesis, Western Blot, Transfection, Expressing, Fluorescence, Immunostaining, Immunocytochemistry, Isolation